InnoCare Pharma Limited (SHA:688428)
China
· Delayed Price · Currency is CNY 20.60
+0.15 (0.73%)
At close: May 9, 2025, 2:57 PM CST
InnoCare Pharma Revenue
In the year 2024, InnoCare Pharma had annual revenue of 1.01B CNY with 36.68% growth. InnoCare Pharma had revenue of 311.70M in the quarter ending December 31, 2024, with 54.94% growth.
Revenue
1.01B
Revenue Growth
+36.68%
P/S Ratio
18.72
Revenue / Employee
926.95K
Employees
1,089
Market Cap
18.89B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |